Roche Holding AG (ROP.SW) — Quality & forensics
As of 2026-11-10 — refreshed nightly. Closelooknet readings from an investment research diary, not ratings or advice.
The Closelooknet module scores
- Valuation 51
- Quality 84
- Growth 21
- Balance sheet 60
- Cash quality 53
- Capital allocation 47
- Momentum 83
Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.
Financial forensics — the academic screens
Sits in the safe zone (above 2.99). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.
Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.
Screens reported earnings for statistical manipulation patterns — below the −1.78 manipulation-risk threshold. A screen, not an accusation.
Continue: the ROP.SW chart & overview
FAQ · from the current data · as of 2026-11-10
Quick answers
What is Roche Holding AG's Closelooknet quality reading?
The composite reads 56/100 across 7 modules, as of 2026-11-10: valuation 51, quality 84, growth 21, balance sheet 60, cash quality 53, capital allocation 47, momentum 83. Closelooknet scores are research diary readings, not ratings or investment advice.
What is Roche Holding AG's Altman Z-Score?
5.02, which sits in the safe zone (above 2.99) as of 2026-11-10. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.
What is Roche Holding AG's Piotroski F-Score?
6 of 9, as of 2026-11-10. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.
What does Roche Holding AG's Beneish M-Score indicate?
-2.81 — below the −1.78 manipulation-risk threshold, as of 2026-11-10. The M-Score screens reported earnings for statistical manipulation patterns; it is a screen, not an accusation.
Related in the Closelooknet universe
- HALO Halozyme Therapeutics Incsector
- ARGX.BR Argen-Xsector
- ONC BeOne Medicines AGsector
- ANN.AU Ansell Ltdsector
- LLY Eli Lilly and Companysector
- ROVI.MC Laboratorios Farmaceuticos ROVIsector
- REGN Regeneron Pharmaceuticals Incsector
- UCB.BR UCB SAsector
- ARGX argenx NV ADRsector
- ORNAV.HE Orion Oyj Asector
- ORNBV.HE Orion Oyj Bsector
- SAN.PA Sanofi SAsector
- DXCM DexCom Incsector
- HQY HealthEquity Incsector
- MEDP Medpace Holdings Incsector
- FPH.AU Fisher & Paykel Healthcare Corporation Ltdsector
- GMED Globus Medicalsector
- IRWD Ironwood Pharmaceuticals Incsector
- RIGL Rigel Pharmaceuticals Incsector
- SECT-B.ST Sectra AB (publ)sector